Research study online in JAMA Ophthalmology may herald new era of new highly targeted molecular treatment for common condition
Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person’s quality of life. An estimated nine million people in the United State alone suffer from significant DED; millions more may have milder forms or experience discomfort when exposed to low humidity or contact lens use. DED, the most common reason people visit ophthalmologists, is estimated to cost $55 billion in annual direct and indirect costs to society in the nation alone.
In a new study, researchers from the Massachusetts Eye and Ear, Harvard Medical School, and Brigham and Women’s hospital show that topical anakinra (Kineret; Amgen Inc.), a recombinant version of human IL-1Ra approved for treatment of rheumatoid arthritis, significantly reduced dry eye symptoms. Topical use of a protein-based biologic agent in treatment of DED is unprecedented and may herald a new era of highly targeted topical molecular treatments for ocular surface disease. The results of this clinical trial are described online first in JAMA Ophthalmology.
“We began looking at the possible therapeutic effects of IL-1Ra over 10 years ago in my laboratory,” said Reza Dana, M.D., MSc., M.PH., senior author. “This clinical trial was a significant milestone in our research. The results clearly show us not only that we can possibly help the millions of people affected by dry eye disease worldwide, but that biologics such as this have the potential to provide targeted therapies for other ocular ailments, as well.”
Early studies have shown that DED is associated with significant overexpression of inflammatory cytokines, including interleukin 1 (IL-1), in the eye. However the options to treat the inflammatory component of DED have been limited and some of these involved adverse effects. Anti-inflammatory medications such as tetracycline derivatives, topical corticosteroids, and cyclosporine A that have been successfully used in the treatment of DED downregulate the production of IL-1 and upregulate the production of IL-1 receptor antagonist (IL-1Ra) at the ocular surface. The IL-1Ra suppresses IL-1-mediated inflammation by completely inhibiting the binding of IL-1a and IL-1b to IL-1 receptor I. Topical IL-1Ra has been successfully used to treat experimental rodent models of corneal transplant rejection, dry eye disease, allergic conjunctivitis and alkali burn-associated ocular inflammation.
The researchers performed a randomized, double-masked clinical trial designed to assess the safety of efficacy of topical IL-1Ra in patients with DED. Seventy-five participants in the 16-week study were randomly allocated in the 2:2:1 ratio to receive eye lubricant (artificial tear), 2.5% of anakinra or 5% of anakinra. Patients found the anakinra was well tolerated and was significantly more effective than the eye lubricant in improving the signs and symptoms of DED. Anakinra at 2.5% was four times more likely than the eye lubricant to bilaterally eliminate corneal staining, a clinical measurement of ocular surface disease. Topical anakinra also significantly reduced dry eye symptoms six times more effectively than the eye lubricant, which is capable of independently improving the signs of DED. Moreover, termination of anakinra (but not the lubricant) application at week 12 lead to a clear trend toward increased symptoms between weeks 12 and 16, confirming the therapeutic effect of the drug.
“We have never seen results such as this before in a trial to treat dry eye disease. We possibly have found a safe, well tolerated eye drop that can treat the underlying cause of dry eye rather than just temporarily mask the symptoms. We are excited about the positive results we saw in the data and with our patients who found relief in their symptoms and were able to return to some of their normal daily activities,” Dr. Dana said.
The Latest Bing News on:
Dry eye disease
- Dry Eye Syndrome Market is expected to generate a revenue of USD 8.22 Billion by 2030, Globally, at 4.5% CAGR: Verified Market Research®on February 1, 2023 at 6:29 am
Verified Market Research® recently published a report, "Dry Eye Syndrome Market" By Product Type (Tear Stimulators, Artificial ...
- Researchers design contact lens prototype to prevent dry eye syndromeon January 30, 2023 at 8:43 am
There have also been previous attempts to use contact lenses in treating dry eye syndrome, such as graphene-coated lenses designed to minimize moisture loss and self-moisturizing lenses stimulated ...
- Dry Eye Syndrome Treatment Market Size and Share Analysis 2023-2029 by Research Developments, Leading Companies and Growth Forecaston January 30, 2023 at 1:47 am
The “ Dry Eye Syndrome Treatment Market ” Research Report 2023-2029 | Latest 106 Pages Report | It throws light on competitive and thoughtful examination on key market trends, and business tactics.
- Contact lenses to treat dry eye syndromeon January 29, 2023 at 3:59 pm
A collaborative team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a contact lens prototype that is specially designed to prevent contact lens-induced dry eye (CLIDE). The ...
- Five warning signs of 'computer vision syndrome' – and expert tips to better your eyesighton January 28, 2023 at 7:32 am
Optician Tina Patel warned of computer vision syndrome, which occurs when you spend too long looking at electronic screens.
- Two separate eye diseases may contribute to early age-related macular degenerationon January 26, 2023 at 6:31 am
The research, published January 9 in Eye is the first to demonstrate that two different types of deposits in the retina may contribute to early AMD, which can progress to advanced AMD and blindness.
- What is dry eye syndrome and what’s the best treatment?on January 26, 2023 at 1:49 am
Dry eyes are on the rise and everything from screens to makeup to menopause and the Pill can be factors. What can you do for dry eye syndrome? Our eye experts advise ...
- Dry Eye Disease Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsighton January 24, 2023 at 4:00 pm
Jan 25, 2023 (AB Digital via COMTEX) -- DelveInsight’s, “Dry Eye Disease Pipeline Insight, 2022,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Dry ...
- New miniature health device to treat dry eyeon January 21, 2023 at 9:04 pm
A small monitor designed to sit in a tear duct is set to revolutionise the treatment of dry eye by removing the need for regular drops. The innovative 1mm plug is as big as a grain of rice and ...
- Dry Eye Can Occur After Surgery to Correct Crossed Eyeson January 20, 2023 at 11:42 am
Girls were more likely to develop dry eye after surgery, and nondominant eyes are more likely to develop postoperative dry eye.
The Latest Google Headlines on:
Dry eye disease
[google_news title=”” keyword=”dry eye disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
[/vc_column_text]
The Latest Bing News on:
Dry eye treatment
- Dry Eye Syndrome Market is expected to generate a revenue of USD 8.22 Billion by 2030, Globally, at 4.5% CAGR: Verified Market Research®on February 1, 2023 at 6:29 am
Verified Market Research® recently published a report, "Dry Eye Syndrome Market" By Product Type (Tear Stimulators, Artificial Tears, Secretagogue), By Dosage Type (Liquid, Semi-Solid), By Drug Class ...
- Researchers design contact lens prototype to prevent dry eye syndromeon January 30, 2023 at 8:43 am
Current treatments for this condition include rewetting drops ... There have also been previous attempts to use contact lenses in treating dry eye syndrome, such as graphene-coated lenses designed to ...
- Dry Eye Syndrome Treatment Market Size and Share Analysis 2023-2029 by Research Developments, Leading Companies and Growth Forecaston January 30, 2023 at 1:47 am
The “ Dry Eye Syndrome Treatment Market ” Research Report 2023-2029 | Latest 106 Pages Report | It throws light on competitive and thoughtful examination on key market trends, and business tactics.
- Contact lenses to treat dry eye syndromeon January 29, 2023 at 3:59 pm
A collaborative team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a contact lens prototype that is specially designed to prevent contact lens-induced dry eye (CLIDE). The ...
- 7 Simple Ayurvedic Remedies To Keep Your Eyes Healthyon January 27, 2023 at 7:33 pm
The use of digital devices has grown significantly over the years, which has contributed to various eye diseases. People have access to their phones 24*7 and are mostly engaged in binge-watching.
- What is dry eye syndrome and what’s the best treatment?on January 26, 2023 at 1:49 am
Dry eyes are on the rise and everything from screens to makeup to menopause and the Pill can be factors. What can you do for dry eye syndrome? Our eye experts advise ...
- Ken Jeong reups for Xiidra campaign to promote dry eye treatmenton January 25, 2023 at 4:00 pm
Novartis’ dry eye disease treatment. Starring as “Real Dry Eye Patient” in a mock movie trailer, Jeong experiences the symptoms of dry eye disease caused by inflammation and uses Xiidra to treat so he ...
- Expert Advice: What Can I Do To Soothe Dry Eye?on January 25, 2023 at 4:43 am
If you are sensitive to light with blurry vision or have red, scratchy, burning eyes, you may be experiencing dry eye. Almost anyone can suffer from this condition, but according to the National Eye ...
- New miniature health device to treat dry eyeon January 21, 2023 at 9:04 pm
A small monitor designed to sit in a tear duct is set to revolutionise the treatment of dry eye by removing the need for regular drops. The innovative 1mm plug is as big as a grain of rice and ...
- Dry Eye Syndrome Treatment Market Size 2023 (New Report) to Experience a Significant Increase in Revenues by 2027 | 106 Pages Reporton January 20, 2023 at 12:47 am
“The global Dry Eye Syndrome Treatment market size was valued at USD 3201.89 million in 2021 and is expected to expand at a CAGR of 5.03% during the forecast period, reaching USD 4298.32 million ...
The Latest Google Headlines on:
Dry eye treatment
[google_news title=”” keyword=”dry eye treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]